Pattern Of Nicotine Use And Dependence In Psychiatric Patients Study

Background: Tobacco use is an epidemic known as “the brown plague” affec?ng one billion lives in the 21st century and 80% in developing countries. Prevalence of smoking is especially high in pa?ents with psychiatric illness with an ongoing debate over which comes first. Studies about nico?ne consump?on in psychiatric pa?ents are few from developing countries. Hence, this study is designed to iden?fy socio-demographic and diagnos?c correlates of nico?ne use. Aims and Objec?ves:- To es?mate the pa?ern of nico?ne use and determine the associa?on between sociodemographic profile, onset of nico?ne use, it’s use as a coping mechanism, psychological associa?on with nico?ne use in psychologically ill pa?ents. Material and methods:- A cross-sec?onal study including 101 pa?ents with nico?ne use and psychiatric illness were administered a semi structured ques?onnaire, Fagerstrom Test for Nico?ne Dependence(FTND) and nico?ne dependence syndrome scale. Data analyzed with mean, standard devia?on, chi- square, ANOVA Results:-Nico?ne use was more common in middle age group with alcohol dependence followed by depression. Nico?ne use was not associated with background, socioeconomic status, gender. Majority tried to quit for health but what kept them with nico?ne were drive, stereotypy, con?nuity, priority. Conclusions:- Nico?ne is a commonly abused substance in psychiatric pa?ents without a clear demarca?on about the cause effect rela?onship. The exis?ng study gives few insights into reasons for nico?ne intake which was more so among the produc?ve age group. Hence, there is a need for further research about psychotropic drug interac?ons with nico?ne use and focus on integra?on of nico?ne cessa?on into treatment of other psychiatric disorders rather than separate deaddic?on clinics to alleviate the illness burden.

Depression, anxiety and suicidal ideation/behaviour among persons with epilepsy: Common but underestimated comorbidities in Haryana, North India

@#Background & Objectives: Depression, anxiety and suicide are the main psychiatric comorbidities which are more prevalent among persons with epilepsy (PWE). This study aims to determine the prevalence of depression, anxiety and suicidal ideation/behaviour in PWE and to correlate their clinical profile with psychiatric comorbidities in a population in North India. Methods: This study was conducted at Pt. BD Sharma PGIMS, Rohtak Haryana among PWE attending outpatient clinic at the Department of Neurology. A total of 100 eligible PWE were included in this study. The demographic and clinical history was documented. All patients filled up the Hospital anxiety and depression scale (HADS) and Columbia-suicide severity rating scale (C-SSRS) questionnaire. Results: The prevalence of depression and anxiety among PWE was found to be 60% and 70% respectively and the prevalence of suicidal ideation and suicidal behaviour was 42% and 3% respectively among PWE. Female gender, longer duration of epilepsy, higher seizure frequency, temporal lobe epilepsy, polytherapy, uncontrolled epilepsy and drug resistant epilepsy were found to be positively correlated with these psychiatric comorbidities. Conclusion: This study shows that the prevalence of depression, anxiety and suicidal ideation/ behaviour is high among PWE in Haryana, North India. PWE should be screened for these psychiatric comorbidities to improve their quality of life

Alexitimia y Psoriasis. Revisión bibliográfica / Alexithymia and Psoriasis a review

Resumen La psoriasis es considerada una enfermedad dentro del espectro de las patologías psicosomáticas. Este cuadro presenta diversas comorbilidades tanto somáticas como psicológicas. Dentro de esta última dimensión, las más prevalentes son los trastornos de ansiedad y depresión. Históricamente se ha asociado la evolución de la psoriasis con factores como el estrés; sin embargo, recientes investigaciones destacan que serían más influyentes aspectos propios de la personalidad del paciente, como la alexitimia, más que el evento estresante en particular. La alexitimia presenta alta prevalencia en pacientes con psoriasis y conforme a diversos estudios se relacionaría con implicancias adversas en el curso de la patología cutánea en lo que respecta a la calidad de vida, percepción de enfermedad, comorbilidades, evolución y vulnerabilidad al estrés.

Summary Psoriasis is considered a Psychosomatic disease. It is associated with several comorbidities, not only somatic but also psychiatric and psychological, such as anxiety and depression. Historically, this cutaneous disease has been associated with environmental factors including stress. Recent studies reported that psychological aspects of the patient such as personality traits, including alexithymia, may be more important in the course of the pathology than a stressor factor. Patients affected by psoriasis and alexithymia may be more vulnerable to stress, and this association would be one of the reasons for the disease exacerbations. There is a high prevalence between alexithymia and psoriasis. In accordance with the reviewed articles, alexithymia is related with poor quality of life, abnormal perception of the illness, somatic and psychiatric comorbidities, worse prognosis and vulnerability to stress influence. The intention of this review is to bring an update of the impact of alexithymia in patients affected by psoriasis.

A descriptive study on quality of life, depression and anxiety in chronic urticaria patients attending a tertiary care hospital in Bengaluru, South India

Background: Chronic urticaria (CU) is a common skin disorder characterized by the recurrent appearance of wheals typically associated with pruritis and/or angioedema for more than 6 weeks. It has a significant impact on patient’s quality of life (QoL). Hence it is of utmost importance to identify the impact of CU on the patient’s life and psychiatric comorbidities associated with it. The objectives of the study were to assess the effect of chronic urticaria on the quality of life of the patient; to assess the depression in patients with chronic urticaria; to assess the anxiety in patients with urticaria.Methods: A total of 106 patients with chronic urticaria attending allergy clinic, KIMS Hospital during November-January 2019 (3 months) were included in the study. Informed consent was obtained. Each patient was interviewed using pretested questionnaire developed using chronic urticaria on quality of life: (CU-Q2oL), patient health questionnaire-9 (PHQ-9) and general anxiety disorder-7 (GAD-7). Data was entered in Epi-info7 and descriptive statistics were used.Results: There were 43 (40.6%) males and 63 (59.4%) females. The mean age of the patients was 36.5±11.7 years. Quality of life was affected A lot in 9.5% of the patients and is somewhat affected in 38.7% of the CU patients. As much as 42.5% of them suffered from some grade of depression and 34.9% of them suffered from anxiety.Conclusions: Chronic urticaria has a significant role in impairment of QOL and also leads to mental illnesses such as depression and anxiety.

Biological and Psychological Influences of CrossSex Hormone in Transgender

@#Transgender is a complex state of bio-psycho-social dimension of human sexuality. It encompasses cognitive-emotional-behavior component that makes the person unique in his or her sexual expression. Transgender tend to use cross-sex hormone in order to eradicate their secondary sexual characteristics and to facilitate the shift to their experienced gender. The common masculinising sex hormone use, i.e. Female to Male Treatment Options (FMTO) is testosterone and for feminising hormone i.e. Male to Female Treatment Options (MFTO) is a combination of estrogen with anti-androgen, respectively. Cross-sex hormone, i.e. FMTO, or MFTO has biological and psychological influences on the transgender individuals. Nevertheless, cross-sex hormone may also pose a range of side effect profiles, varies from the biological to psychosocial impact. The psychological impact can be paramount until it causes severe mental-health problems and even suicide. Numerous ranges of bio-psycho-social influence of cross-sex hormone were highlighted in this review as fundamental core knowledge in the art to know practice when dealing with the treatment options. In psychiatry, the change in the biological appearance may have great influence in the transgender individual, especially in the context of psychosocial and cultural perspective

Perfil sociodemográfico e comorbidades psiquiátricas em dependentes químicos acompanhados em comunidades terapêuticas / Sociodemographic profile and psychiatric comorbidities in chemical dependent patients accompanied in therapeutic communities

RESUMO Objetivos Analisar o perfil sociodemográfico, antecedentes pessoais/familiares e a prevalência de comorbidades psiquiátricas em uma amostra de dependentes de álcool e/ou substâncias psicoativas (SPAs) acompanhados em duas comunidades terapêuticas. Métodos Trata-se de um estudo de prevalência, com coleta de dados realizada em uma amostra de 90 entrevistados por meio da aplicação de uma ficha de dados sociodemográficos/antecedentes pessoais e familiares e do Mini International Neuropsychiatric Interview versão Plus (MINI Plus). Os entrevistados foram divididos em três grupos: etilistas (grupo A), dependentes de SPAs ilícitas (Grupo B) e dependentes de álcool e SPAs ilícitas (grupo C). Resultados Observou-se prevalência elevada de comorbidades psiquiátricas (88,8%) e, em específico, do transtorno depressivo maior (TDM) no grupo A (36,7%) e do transtorno de personalidade antissocial nos grupos B e C (46,7% e 30%, respectivamente). Foi possível traçar perfis próprios para cada grupo, havendo convergência quanto aos dados sociodemográficos para os grupos A e C e entre os grupos B e C para as comorbidades psiquiátricas. Conclusão A vulnerabilidade sociodemográfica e a alta prevalência de comorbidades psiquiátricas denotam a fragilidade da população de dependentes químicos. Os perfis próprios de cada grupo evidenciam a importância de tratamento individualizado.

ABSTRACT Objectives Analyze the sociodemographic profile, personal/family antecedents and the prevalence of psychiatric comorbidities in a sample of alcohol and/or psychoactive substances (PAS) accompanied in two therapeutic communities. Methods This is a prevalence study, having gathered data from a sample with 90 interviewee through a form with sociodemographic/personal/family antecedents data and the Mini International Neuropsychiatric Interview (MINI Plus). The interviewee were divided in three groups: alcohol dependent (group A), illicit PAS dependents (group B) and alcohol and illicit PAS (group C). Results A high prevalence of psychiatric comorbidities (88.8%) and, specifically, the major depressive disorder (MDD) in group A (36.7%) and antisocial personality disorder in groups B and C (46.7% and 30%, respectively) was found. It was possible to track characteristic profile for each group, having found a convergence of sociodemographic data for groups A and C, and between groups B and C, for psychiatric comorbidities. Conclusion The sociodemographic vulnerability and the high prevalence of psychiatric comorbidities denote the fragility of the population of chemical dependents. The characteristic profiles for each group demonstrate the importance of an individualized treatment.

Psychiatric comorbidities among adolescents with and without anxiety disorders: a community study / Comorbidades psiquiátricas entre adolescentes com e sem transtornos de ansiedade: um estudo da comunidade

ABSTRACT Objective To evaluate, in a community sample of adolescents, the presence of comorbidities in different anxiety disorders. Methods This is a cross-sectional study, initially composed of 2,457 adolescents, aged between 10-17 years old, from public schools of the area covered by the Basic Health Unit of a university hospital. We applied the Screen for Child Anxiety Related Emotional Disorders (SCARED) to assess for anxiety disorders. Then, 138 positive cases in the screening were assessed for mental disorders through the Schedule for Affective Disorder and Schizophrenia for School-Age Children – Present and Lifetime Version (K-SADS-PL). Results Patients with anxiety disorders had more association with other anxiety disorders, as well as depression, and enuresis. The most common comorbidity described in our study was between generalized anxiety disorder and separation anxiety disorder (OR = 4.21, 95% CI 1.88, 9.58). Significant association was observed between other disorders such as enuresis and separation anxiety disorder (OR = 3.81, 95% CI 1.16, 12.49), as well as depression and generalized anxiety disorder (OR = 3.40; 95% CI 1.52, 7.61). Conclusion Our study showed a relevant presence of comorbidities adolescents with anxiety disorders, selected from a community sample, especially regarding other anxiety disorders. Nevertheless, further studies are needed to confirm our findings.

RESUMO Objetivo Avaliar, em uma amostra comunitária de adolescentes, a presença de comorbidades nos distintos transtornos de ansiedade. Métodos Estudo transversal, composto por 2.457 adolescentes de 10 a 17 anos, provenientes das escolas públicas da área de abrangência da Unidade Básica de Saúde de um hospital universitário, que foram avaliados para transtornos de ansiedade, por meio da Screen for Child Anxiety Related Emotional Disorders (SCARED). Desses, 138 casos foram positivos pela SCARED e avaliados para transtornos mentais, por meio do Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL). Resultados Pacientes com transtornos de ansiedade apresentavam mais comorbidades com outros transtornos de ansiedade, bem como com depressão e enurese. As comorbidades mais frequentes descritas em nosso estudo foram transtorno de ansiedade generalizada e transtorno de ansiedade de separação (OR = 4,21; IC 95% 1,88; 9,58). Foi observada associação significativa com outros transtornos, tais como enurese com transtorno de ansiedade de separação (OR = 3,81; IC 95% 1,16; 12,49) e depressão com transtorno de ansiedade generalizada (OR = 3,40; IC 95% 1,52; 7,61). Conclusão A presença de comorbidades em adolescentes com transtornos de ansiedade selecionados de uma amostra comunitária foi frequente. Estudos complementares para confirmar nossos resultados são necessários.

Psychopathology and psychiatric co-morbidities in patients seeking rhinoplasty for cosmetic reasons / Psicopatología y comorbilidad psiquiátrica en pacientes que buscan rinoplastia por razones cosméticas

AIM: The purpose of the study was to examine psychopathological traits and psychiatric co-morbidities in seekers of cosmetic rhinoplasty. SUBJECTS AND METHOD: Fifty persons seeking cosmetic rhinoplasty and 50 control subjects were admitted to the study. Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI) and Symptom Checklist - 90 [Revised] (SCL-90-R) were administered to people who requested cosmetic rhinoplasty and control subjects. All participants were also screened by the Structured Clinical Interview for DSM-IV-(SCIDI/ CV, SCID-II). RESULTS: Thirteen cosmetic rhinoplasty seekers [CRS] (26%) and three control subjects (6%) had at least one psychiatric diagnosis. There was a significant difference between the two groups (p = 0.006). Beck depression inventory (p = 0.002) and BAI (p = 0.046) levels above the cut-off point were significantly higher in the CRS group than in the normal control. Somatoform disorders were statistically higher in the CRS than control group (p = 0.007). Nine CRS (18%) and two control subjects (4%) had at least one personality disorder. There were differences between the two groups (p = 0.025). The average of SCL-90-R was significantly higher in the CRS than in the control subjects (p < 0.001). The most prevalent somatoform disorders of the CRS were six with body dysmorphic disorder [BDD] (12%). The most prevalent personality disorders of the CRS were three with avoidant (6%) and three with narcissistic (6%) personality. CONCLUSION: Assessment of detailed psychopathological aspects and psychiatric co-morbidities could help to define the clinical profile of people requesting cosmetic rhinoplasty in cosmetic surgery settings. Research into these factors may be important as it is essential to detect crucial problems such as personality disorders and BDD before surgery.

OBJETIVO: El propósito del estudio fue examinar los rasgos psicopatológicos y las comorbilidades psiquiátricas en los solicitantes de rinoplastia cosmética. SUJETOS Y MÉTODO: Cincuenta personas que buscaban rinoplastia cosmética, y 50 sujetos de control fueron registrados en el estudio. El Inventario de Depresión de Beck (BDI), el Inventario de Ansiedad de Beck (BAI), y el Listado de Síntomas 90 (Revisado) (SCL 90), fueron aplicados a las personas que solicitaron rinoplastia cosmética y a los sujetos del control. Todos los participantes fueron también sometidos a tamizaje mediante la Entrevista Clínica Estructurada para DSM - IV-(SCID-/ CV, SCIDII). RESULTADOS: Trece solicitantes de rinoplastia cosmética solicitantes (SRC) (26%) y tres sujetos de control (6%) tuvieron al menos un diagnóstico psiquiátrico. Hubo una diferencia significativa entre los dos grupos (p = 0.006). Los niveles de BDI (p = 0,002) y BAI (p = 0.046) por encima del valor límite, fueron significativamente más altos en el grupo de SRC que en el grupo control normal. Los trastornos somatoformes fueron estadísticamente más altos en el grupo SRC que en el grupo control (p = 0.007). Nueve SRC (18%) y dos sujetos de control (4%) tenían al menos un trastorno de personalidad. Hubo diferencias entre los dos grupos (p = 0. 025). El promedio de SCL-90-R fue significativamente más alto en el grupo de SRC que en los sujetos del grupo control (p < 0.001). Los trastornos somatoformes más prevalentes de SRC fueron seis con trastorno dismórfico corporal (TDC) (12%). Los trastornos de personalidad más prevalentes de SRC fueron: tres con trastorno de la personalidad por evitación (6%) y tres con personalidad narcisista (6%). CONCLUSIÓN: La evaluación de los aspectos psicopatológicos detallados y las comorbilidades psiquiátricas podrían ayudar a definir el perfil clínico de las personas que solicitan rinoplastia cosmética en los escenarios de cirugía cosmética. La investigación en estos factores puede ser importante, ya que es esencial para detectar problemas cruciales tales como los trastornos de personalidad y TDC antes de la cirugía.

Psychiatric comorbidities in temporal lobe epilepsy: possible relationships between psychotic disorders and involvement of limbic circuits / Comorbidades psiquiátricas na epilepsia do lobo temporal: possíveis relações entre desordens psicóticas e comprometimento de circuitos límbicos

OBJECTIVE: Mounting evidence suggests that the limbic system is pathologically involved in cases of psychiatric comorbidities in temporal lobe epilepsy (TLE) patients. Our objective was to develop a conceptual framework describing how neuropathological and connectivity changes might contribute to the development of psychosis and to the potential neurobiological mechanisms that cause schizophrenia-like psychosis in TLE patients. METHODS: In this review, clinical and neuropathological findings, especially brain circuitry of the limbic system, were examined together to enhance our understanding of the association between TLE and psychosis. Finally, the importance of animal models in epilepsy and psychiatric disorders was discussed. CONCLUSIONS: TLE and psychiatric symptoms coexist more frequently than chance would predict. Damage and deregulation among critical anatomical regions, such as the hippocampus, amygdala, thalamus, and the temporal, frontal and cingulate cortices, might predispose TLE brains to psychosis. Studies of the effects of kindling and injection of neuroactive substances on behavior and electrophysiological patterns may offer a model of how limbic seizures in humans increase the vulnerability of TLE patients to psychiatric symptoms.

OBJETIVO: Existem cada vez mais evidências de que o sistema límbico está envolvido na patologia das comorbidades psiquiátricas em pacientes com epilepsia do lobo temporal (ELT). Nosso objetivo foi elaborar um desenho conceitual descrevendo como aspectos neuropatológicos e de conectividade podem contribuir para o desenvolvimento de psicose em pacientes com ELT. MÉTODOS: Nesta revisão, achados clínicos e neuropatológicos, e especialmente os aspectos da circuitaria límbica, foram examinados em conjunto para auxiliar nossa compreensão sobre a associação entre ELT e psicose. Achados em modelos animais de epilepsia e esquizofrenia também foram levados em consideração. CONCLUSÕES: ELT e comorbidades psiquiátricas coexistem com maior frequência que o predito pela associação ao acaso. Dano e desregulação entre estruturas anatômicas críticas, como hipocampo, amígdala, tálamo, e córtices temporal, frontal e cingulado podem predispor o cérebro com ELT à psicose. Estudos sobre efeitos comportamentais e eletrofisiológicos do abrasamento elétrico e injeções de substâncias neuroativas em modelos animais podem oferecer pistas sobre como crises límbicas em humanos aumentam a vulnerabilidade de pacientes com ELT a sintomas psiquiátricos.

Pathophysiology of mood disorders in temporal lobe epilepsy / Fisiopatologia dos transtornos de humor na epilepsia do lobo temporal

OBJECTIVE: There is accumulating evidence that the limbic system is pathologically involved in cases of psychiatric comorbidities in temporal lobe epilepsy (TLE) patients. Our objective was to develop a conceptual framework describing how neuropathological, neurochemical and electrophysiological aspects might contribute to the development of psychiatric symptoms in TLE and the putative neurobiological mechanisms that cause mood disorders in this patient subgroup. METHODS: In this review, clinical, experimental and neuropathological findings, as well as neurochemical features of the limbic system were examined together to enhance our understanding of the association between TLE and psychiatric comorbidities. Finally, the value of animal models in epilepsy and mood disorders was discussed. CONCLUSIONS:TLE and psychiatric symptoms coexist more frequently than chance would predict. Alterations and neurotransmission disturbance among critical anatomical networks, and impaired or aberrant plastic changes might predispose patients with TLE to mood disorders. Clinical and experimental studies of the effects of seizures on behavior and electrophysiological patterns may offer a model of how limbic seizures increase the vulnerability of TLE patients to precipitants of psychiatric symptoms.

OBJETIVO: Há evidências crescentes do envolvimento do sistema límbico nas comorbidades psiquiátricas associadas à epilepsia do lobo temporal (ELT). Nosso objetivo foi descrever o panorama atual das alterações neuropatológicas, neuroquímicas e eletrofisiológicas que podem contribuir para o desenvolvimento de sintomas psiquiátricos na ELT e explorar possíveis mecanismos neurobiológicos que podem levar ao aparecimento das desordens de humor nesse subgrupo de pacientes. MÉTODOS: Achados clínicos, de modelos experimentais e neuropatológicos foram revistos, assim como características neuroquímicas do sistema límbico foram examinadas em conjunto para auxiliar nossa compreensão sobre a associação entre ELT e transtornos de humor. CONCLUSÕES: A ELT e os sintomas psiquiátricos coexistem numa frequência muito maior do que o acaso poderia sugerir. Alterações e desregulação de redes anatômicas essenciais, além de mudanças plásticas aberrantes ou deficientes, podem predispor o cérebro de pacientes com ELT a transtornos de humor. Estudos experimentais e clínicos sobre o efeito das crises no comportamento e nos padrões eletrofisiológicos podem oferecer um modelo de como as crises límbicas aumentam a vulnerabilidade a sintomas psiquiátricos em pacientes com ELT.

Assesment of psychiatric symptoms and co-morbidities in patients with irritable bowel syndrome / Evaluación de los síntomas psiquiátricos y las comorbilidades en pacientes con el síndrome del intestino isrritable

AIM: To determine the psychiatric symptom assesment of patients seeking treatment for irritable bowel syndrome (IBS) and to demonstrate the presence of more complicated psychiatric disorders. SUBJECTS AND METHOD: The participants were recruited from patients who were attending internal medicine and gastroenterology clinics and who fullfilled the Rome III criteria for IBS. Fifty patients with IBS (IBS group) and 50 patients with complaints other than gastrointestinal symptoms (control group) were randomly selected. All participants were screened by the Structured Clinical Interview for DSM-IV (SCID-I), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Symptom Check list - 90 (Revised) [SCL-90-R]. RESULTS: Seventeen patients (34%) and three control subjects (6%) had at least one psychiatric diagnosis (p = 0.001). Global severity index (GSI) total scores and SCL-90-R items were significantly higher in the IBS group than the control group (0.92 ± 0.46 vs 0.358 ± 0.19, p < 0.001). Beck anxiety inventory and BDI scores were higher in the IBS group than the control group (p < 0.001). Axis-I psychiatric disorders diagnosed with SCID-I were significantly higher in the IBS group (34% vs 6%) [p = 0.001]. Among the Axis-I disorders, somatoform and anxiety disorders were higher in the patient group than in the control subjects (p = 0.002 and p = 0.0057) whereas there was no difference for mood disorders (p = 0.204). Seven (14%) of the patients and two (4%) of the control subjects had at least one Axis-II psychiatric disorder diagnosed with SCID-II without any significance (p = 0.159). CONCLUSION: These findings suggest that except for mood and personality disorders, almost all psychiatric symptoms and disease co-morbities with IBS are higher than in the sample without IBS. We can easily use SCL-90-R, BAI and BDI in internal medicine and gastroenterology clinics to detect psychiatric symptom levels and then to refer patients to a psychiatrist for further evaluation and treatment.

OBJETIVO: Determinar la evaluación del síntoma psiquiátrico de pacientes que buscan tratamiento para el síndrome del intestino irritable (IBS), y demostrar la presencia de trastornos psiquiátricos más complicados. SUJETOS Y MÉTODO: Los participantes reclutados fueron pacientes que asistían a clínicas de medicina interna y gastroenterología, y satisfacían los criterios de Roma III para el IBS Cincuenta pacientes con IBS (grupo IBS) y 50 pacientes aquejados de otras dolencias no gastrointestinales (grupo control) fueron seleccionados al azar. Todos los participantes pasaron por el tamiz de la Entrevista Clínica Estructurada para DSM-IV (SCID-I), el Inventario de Depresión de Beck (BDI), el Inventario de Ansiedad de Beck (BAI), y el Listado de Síntomas-90 (Revisado) [SCL-90-R]. RESULTADOS: Diecisiete pacientes (34%) y tres sujetos de control (6%) tenían al menos un diagnóstico psiquiátrico (p = 0.001). Las puntuaciones totales del índice de severidad global (GSI) y los ítems del SCL-90-R fueron significativamente más altos en el grupo de IBS que en el grupo control (0.92 ± 0.46 frente a 0.358 ± 0.19, p < 0.001). Las puntuaciones del Inventario de Ansiedad de Beck y BDI fueron más altas en el grupo IBS que el grupo control (p < 0.001). Los trastornos psiquiátricos del eje I diagnosticados con SCID-I fueron significativamente más altos en el grupo IBS (34% vs. 6%) [p = 0.001]. Entre los desórdenes del Eje I, los trastornos somatoformos y los trastornos de ansiedad fueron más altos en el grupo de pacientes que en los sujetos del control (p = 0.002) y (p = 0.0057), en tanto que no hubo ninguna diferencia en cuanto a los trastornos de estados de ánimo (p = 0.204). Siete (14%) de los pacientes y dos (4%) de los sujetos del control tuvieron por lo menos un trastorno psiquiátrico del eje II diagnosticados con el SCID-II sin ninguna significación (p = 0.159). CONCLUSIÓN: Estos hallazgos sugieren que salvo el caso de los trastornos de estados de ánimo y personalidad, casi todos los síntomas psiquiátricos y comorbilidades con el IBS son más altos que en la muestra sin IBS. Se puede usar con facilidad el SCL-90-R, el BAI y el BDI en las clínicas de medicina interna y gastroenterología para detectar los niveles de síntomas psiquiátricos, y remitir entonces a los pacientes a un psiquiatra para ulterior evaluación y tratamiento.

A Comparative Study of Phenomenology, Psychiatric Co-Morbidities and Global Functioning of People with ADHD from Childhood to Adulthood.

Introduction: Although previously thought to remit largely in adolescence, a growing literature supports the persistence of the disorder and/or associated impairment into adulthood. Studies in India are lacking on ADMD. Aims and Objectives: To compare the phenomenology of ADHD in childhood, adolescence and adulthood, to compare the psychiatric co-morbidities with ADHD in childhood, adolescence and adulthood, to compare the global functioning of subjects with ADHD in childhood, adolescence and adulthood. Methods: A statistical comparison was made between studies done in dept. of psychiatry, CSMMU UP, Lucknow on childhood, adolescent and adult ADHD for its various aspects. Conclusions: Hyperactivity-impulsivity decreases as subjects with ADHD grow up and inattention symptoms become more impairing, ADHD is highly co-morbid across all age groups but the nature of co-morbidities change, functioning of subjects with ADHD improve as they grow older.

Psychopathological evaluation of patients requesting cosmetic rhinoplasty a review / Evaluación psicopatológica de pacientes que requieren rinoplastia cosmética una revisión

OBJECTIVE: The goal of this review is to discuss possible underlying psychopathological situations in patients requesting surgical cosmetic rhinoplasty operation and to examine potential problems that might arise. SUBJECTS AND METHODS: An extensive search was conducted through PubMed, Ambase and PsychInfo by using related keywords in English, like "rhinoplasty and psychiatric comorbidities ", "rhinoplasty and psychopathology". RESULTS: Patients who demand cosmetic rhinoplasty operation appealed to the surgeon since they wanted to feel better about themselves after the surgery. Indeed, some long-term studies determined that such a situation can take place at high rates. However, some studies reported the possibility of serious psychological disorders after such surgical operations. Studies relating to the analysis of psychopathologic symptoms are quite limited. Research has shown that psychopathologic evaluation conducted preoperatively is especially important to identify serious psychopathologies such as personality disorders and body dysmorphic disorder (BDD). CONCLUSIONS: Exclusion of patients possessing serious psychopathologies from operations provides better results in the long term. The lack of sufficient research in this area necessitates new and comprehensive studies.

OBJETIVO: El propósito de esta revisión es discutir las posibles situaciones psicopatológicas detrás de pacientes que solicitan la operación de rinoplastia quirúrgica cosmética, y examinar problemas potenciales que podrían suscitarse. SUJETOS Y MÉTODOS: Se llevó a cabo una búsqueda extensa a través de PubMed, Ambase y PsychInfo usando palabras claves en inglés, como "rinoplastia y comorbidades psiquiátricas " "rinoplastia y psicopatología ". RESULTADOS: Pacientes que solicitaban una operación de rinoplastia cosmética, apelaron al cirujano expresando que deseaban sentirse mejor luego de la cirugía. En realidad, algunos estudios a largo plazo determinaron que una situación semejantepuede tener una alta tasa de ocurrencia. Sin embargo, otros estudios reportan la posibilidad de trastornos psicológicos serios Los estudios que se refieren al análisis de síntomas psicopatológicos, son muy limitados. Las investigaciones han demostrado que realizar una evaluación psicopatológica antes de la operación, es en extremo importante [ara identificar serias psicopatologías tales como trastornos de la personalidad y Trastorno Dismórfico Corporal (TDC). CONCLUSIONES: El excluir a los pacientes con serias psicopatologías de las operaciones arroja mejores resultados a largo plazo. La insuficiente investigación en esta área apunta a la necesidad de que se realicen estudios nuevos y abarcadores.

Prevalência de transtorno de pânico em pacientes com zumbidos / The prevalence of panic disorder in patients with tinnitus

CONTEXTO: Estudos sugerem associação entre zumbidos e transtornos psiquiátricos. OBJETIVO: Identificar a presença de transtorno de pânico em uma amostra de pacientes com queixas de zumbido. MÉTODO: Foram avaliados 50 pacientes com queixa primária de zumbido de um serviço ambulatorial de otorrinolaringologia, durante um período de dois meses. A identificação de transtornos psiquiátricos e do impacto do zumbido na qualidade de vida foi feita por meio do Mini International Neuropsychiatric Interview (MINI versão 5.0) e do Tinnitus Handicap Inventory. Todos os pacientes foram submetidos à avaliação audiológica e responderam a um questionário clínico-demográfico desenvolvido para este estudo. RESULTADOS: Vinte (40 por cento) pacientes apresentaram transtorno de pânico, sendo 8 com e 12 sem agorafobia; 41 (82 por cento) pacientes apresentaram pelo menos um diagnóstico psiquiátrico, sendo os mais prevalentes: transtorno de pânico (40 por cento), depressão maior (40 por cento) e transtorno de ansiedade generalizada (34 por cento). CONCLUSÃO: A prevalência de transtorno de pânico em nossa amostra de pacientes com zumbidos foi elevada, o que ratifica a importância da avaliação psiquiátrica nesses pacientes.

BACKGROUND: Many studies suggest there is an association between tinnitus and psychiatric disorders. OBJECTIVE: To identify the prevalence of panic disorder in a tinnitus patients' sample. METHOD: We evaluated 50 patients with the main complaint of tinnitus of an Otorhinolaryngology outpatient unit for two consecutive months. The evaluation of psychiatric disorders was made with the Mini International Neuropsychiatric Interview (M.I.N.I version 5.0) and the evaluation of the tinnitus' impact was made with the Tinnitus Handicap Inventory. All patients also were submitted to an audiological evaluation and answered a clinical-demographic questionnaire elaborated for this study. RESULTS: Twenty (40 percent) patients had panic disorder, 8 with agoraphobia and 12 without agoraphobia; 41 patients (82 percent) had at least one psychiatric disorder, and the most prevalent were: panic disorder (40 percent), major depression (40 percent) and generalized anxiety disorder (34 percent). DISCUSSION: The prevalence of panic disorder in this sample of tinnitus' patients was high, which reinforces the importance of a psychiatric evaluation on these patients.

Stigma in Patients with Drug Refractory Epilepsy: the Risk Factor, Psychiatric Comorbidities, and Quality of Life / 대한간질학회지

PURPOSE: Stigma is more likely to be reported by people with epilepsy with frequent seizures and associated with various physical and psychosocial factors. We determined risk factors associated with stigma, and investigated the impact of felt stigma on psychiatric comorbidities and quality of life (QOL) in patients with drug refractory epilepsy (DRE). METHODS: Patients with DRE of partial onset, who experienced a failure of at least two antiepileptic drugs (AEDs) and at least 1/month of seizure attack for recent 6 months, were enrolled in the study. We divided patients into two groups according to the presence of stigma. We compared demographic and clinical variables, mood, anxiety, psychiatric symptoms, and QOL between two groups. RESULTS: Among 75 patients with DRE of partial onset, 34 patients (45%) had stigma. Risk factors associated with stigma were age, history of psychiatric disease, duration of epilepsy, and duration of AEDs intake. However, seizure frequency was not associated with the occurrence of stigma. Mood, anxiety, and psychiatric symptoms were significantly higher in patients with stigma than those without stigma. QOL was significantly lower in patients with stigma than those without stigma. CONCLUSIONS: A longer duration of epilepsy with previous history of psychiatric diseases may be indispensable for the occurrence of stigma in patients with DRE. Early detection and appropriate treatment of psychiatric comorbidities can lessen the degree of stigma and improve QOL.

Psicose e depressão na epilepsia do lobo temporal: [revisão] / Psychosis and depression in temporal lobe epilepsy: [review]

INTRODUÇÃO: A epilepsia traz consigo um risco aumentado de desenvolvimento de distúrbios psiquiátricos. Pacientes com epilepsia parcial têm um risco maior do que aqueles com epilepsia generalizada idiopática. Além disso, a condição crônica das crises parece ser um fator importante no risco aumentado. Os sintomas resultam de mecanismos psicopatológicos muito diversos entre os pacientes. As classificações são baseadas na sintomatologia psiquiátrica, na presença ou ausência de distúrbios da consciência, em anormalidades do EEG e na relação temporal entre os sintomas e as crises. RESULTADOS: Comorbidades psiquiátricas em epilepsia são muito freqüentes, especialmente aquelas que têm o lobo temporal como área epileptogênica principal. As desordens com maior prevalência são os distúrbios de humor como depressão maior, ansiedade e psicose. CONCLUSÃO: A epilepsia do lobo temporal per se, não pode ser considerada um fator de risco para o desenvolvimento de sintomas psiquiátricos, ou mais severos, dentre os pacientes com epilepsia parcial. Fatores concomitantes como duração da epilepsia e freqüência de crises podem ter um papel adicional importante. O reconhecimento mais acurado das comorbidades psiquiátricas poderá ajudar no desenvolvimento e implementação de programas apropriados de diagnóstico e tratamento, assim como melhorar o devir e a qualidade de vida dos pacientes com epilepsia.

INTRODUCTION: Several studies have reported an increased risk for psychiatric disturbances in patients with epilepsy. It is assumed that the risk is higher for patients with partial epilepsy in comparison with patients with idiopathic generalized epilepsy. Besides, the persistence of seizures in some patients and the psychosocial impact of epilepsy seem to be important factors for the increased risk. The symptoms and the underlying psychopathology vary considerably among patients. Psychiatric comorbidities are based on the psychiatric symptomatology, the presence or absence of disturbance of consciousness, the EEG abnormalilies, and in the temporal relation between symptoms and seizures. RESULTS: Psychiatric comorbidities in epilepsy are very common, especially in patients who have the temporal lobe as epileptogenic foci. Psychiatric disorders with a high prevalence in epilepsy include mood disorders such as major depression, anxiety, and psychosis. CONCLUSION: Temporal lobe epilepsy per se cannot be considered a risk factor in developing more or more severe symptoms of psychopathology in patients with partial epilepsy. Concomitant factors, such as the duration of epilepsy and seizure frequency may play an additional role. Better recognition of psychiatric comorbidities will help to develop and implement appropriate diagnostic and treatment programs, and improve functional outcomes and quality of life in people with epilepsy.

Psychogenic nonepileptic seizures: an overview / Crises não-epilépticas psicogênicas: uma revisão

Pyschogenic nonepileptic seizures (PNES) are common and potentially harmful - both physically and emotionally - events. They are often under or misdiagnosed. Not only neurologists managing epilepsy, but also generalists and ER physicians should be aware of its existence, preventing unnecessary tests, as well as, iatrogenic interventions. The assistance provided to these patients is often inadequate, even at larger and busier epilepsy centers. That clearly impacts on the prognosis of this condition, which is fairly difficult to manage per se, yet with the best possible quality of care, including well trained multiprofessional teams.

Crises não-epilépticas psicogênicas (CNEP) são eventos comuns e potencialmente prejudiciais, tanto física quanto emocionalmente. São comumente subdiagnosticas ou mesmo diagnosticas erroneamente. Não apenas neurologistas envolvidos com o tratamento de epilepsia, mas também clínicos gerais e principalmente médicos em unidades de emergência deveriam estar cientes de sua existência, evitando exames desnecessários e possível iatrogênese. A assistência a estes pacientes é frequentemente inadequada, mesmo em grandes centros de atendimento a epilepsia, aspecto que impacta de forma definitiva no prognóstico destes pacientes. O manejo destes casos é habitualmente difícil, mesmo em ambientes com equipes multiprofissionais bem treinadas com este propósito.

Comorbidade psiquiátrica diminui a qualidade de vida de pacientes com enxaqueca crônica / Psychiatric comorbidities decrease quality of life in chronic migraine patients

INTRODUÇÃO: A enxaqueca apresenta elevada comorbidade com os transtornos de humor e de ansiedade e extremo impacto no grau de incapacidade e qualidade de vida do indivíduo afetado, mas pouco se sabe sobre a qualidade de vida dos pacientes com enxaqueca crônica e o impacto das comorbidades psiquiátricas. MÉTODO: Cinquenta pacientes com diagnóstico de enxaqueca crônica (Sociedade Internacional de Cefaléias, 2004) foram diagnosticados quanto à presença de transtornos mentais, através da entrevista estruturada SCID-I/P e do questionário de qualidade de vida SF-36. Pacientes foram divididos nos seguintes grupos: enxaqueca crônica com transtornos de ansiedade, transtorno de ansiedade generalizada, transtornos de ansiedade com pelo menos um episódio depressivo maior, com episódio depressivo maior, comparados a pacientes sem comorbidade psiquiátrica. RESULTADOS: Constatou-se qualidade de vida significativamente inferior nos oito domínios da SF-36, nos pacientes com enxaqueca crônica associada a comorbidade psiquiátrica tais como transtornos de ansiedade, transtorno de ansiedade generalizada, transtornos de ansiedade com pelo menos um episódio depressivo maior, assim como nos pacientes apenas com episódio depressivo maior, comparados a pacientes com enxaqueca crônica sem comorbidade psiquiátrica (p<0,05). Somente no domínio Estado Geral de Saúde do SF-36, a qualidade de vida não foi significativamente inferior em todos os grupos de pacientes com enxaqueca crônica associada a comorbidade psiquiátrica. Nos domínios do SF-36 relacionados aos aspectos físicos, a qualidade de vida não foi significativamente inferior somente nos transtornos de ansiedade. CONCLUSÃO: A comorbidade da enxaqueca crônica e transtornos mentais é fator associado à piora da qualidade de vida dos pacientes e deve ser ativamente pesquisada nesta população.

INTRODUCTION: Chronic migraine is a common, debilitating condition affecting quality of life and social functioning with significant impact. Migraine is highly comorbid with anxiety and mood disorders, but little is known about psychiatric comorbidities impact in the migraine patient quality of life. METHOD: Fifty patients with chronic migraine diagnosed according to the International Headache Society (2004) were interviewed and met diagnostic criteria for mental disorders, according to the structured interview SCID-I/P and were evaluated by the SF-36 Health Survey questionnaire. Patients were divided in the following groups: chronic migraine with both mood and anxiety disorders, with only anxiety disorders, with generalized anxiety disorder, with only a mood disorder, and without psychopathology. The scores in the group without psychopathology were compared with the other groups. All eight domains of the SF-36 scale were compared in those groups. RESULTS: Significantly lower (p<0.05) quality of life was found on all eight SF-36 domains for CM psychiatric comorbidity patients compared to no-co morbidity patients. On the SF-36 General Health domain alone, quality of life was not significantly lower for all four CM psychiatric comorbidity groups. On the SF-36 Physical Aspects domain alone, quality of life was not significantly lower only for the Anxiety Disorders group. CONCLUSION: Chronic migraine comorbidity with mental disorder is a significant factor affecting patients' quality of life.